ANVS

Annovis Bio Inc

NYSE: ANVS · HEALTHCARE · BIOTECHNOLOGY

$1.75

-1.13% today

Updated 2026-07-31

Market cap

$74.02M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.70

Dividend yield

—

52W range

$2 – $6

Volume

1.0M

Market cap

$74.02M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.70

Dividend yield

—

52W range

$2 – $6

Volume

1.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

4.5

Quality

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$11.00

+528.57%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Piotroski 3/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-9.01M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-25.15M	$-56.20M	$-24.59M	$-28.85M	$-17.61M
EPS	—	—	—	—	$-1.70
Free cash flow	$-17.31M	$-39.97M	$-21.89B	$-25.62B	$-9.01M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ANVS	$74.02M	17	4.3	3.0	5.0	4.5	—	Avoid
LLY	$1.02T	76	10.0	10.0	4.3	6.0	—	Strong Buy
JNJ	$615.36B	57	4.7	8.5	4.3	6.0	—	Buy
ABBV	$447.53B	63	4.0	8.0	4.7	5.0	-78.83%	Buy
UNH	$391.69B	62	7.3	5.5	4.0	6.0	-30.51%	Buy
MRK	$307.25B	50	3.3	8.0	2.7	5.0	-62.28%	Hold

Smart narrative

Annovis Bio Inc trades at $1.75. Our Smart Value Score of 17/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score.

Frequently asked questions

What is Annovis Bio Inc's stock price?

Annovis Bio Inc (ANVS) trades at $1.75.

Is Annovis Bio Inc overvalued?

Annovis Bio Inc carries a Smart Value Score of 17/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Annovis Bio Inc (ANVS)?

The 12-month analyst consensus target is $11.00, about 528.6% above the current $1.75. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNYSE

CurrencyUSD

www.annovisbio.com

Quick metrics

P/S ratio—

ROE-220.60%

Beta1.19

50D MA$1.89

200D MA$2.52

Shares out0.04B

Float0.03B

Short ratio—

Avg volume1.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

ANVS vs LLY →ANVS vs JNJ →ANVS vs ABBV →Stock screener →